Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.
about
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis.Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.Monoacylglycerol-enriched oil increases EPA/DHA delivery to circulatory system in humans with induced lipid malabsorption conditions.
P2860
Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Diagnosing malabsorption with ...... subjects with cystic fibrosis.
@ast
Diagnosing malabsorption with ...... subjects with cystic fibrosis.
@en
type
label
Diagnosing malabsorption with ...... subjects with cystic fibrosis.
@ast
Diagnosing malabsorption with ...... subjects with cystic fibrosis.
@en
prefLabel
Diagnosing malabsorption with ...... subjects with cystic fibrosis.
@ast
Diagnosing malabsorption with ...... subjects with cystic fibrosis.
@en
P2093
P2860
P356
P1476
Diagnosing malabsorption with ...... subjects with cystic fibrosis.
@en
P2093
Jeffrey S Barrett
Joan I Schall
John T Mondick
Maria R Mascarenhas
Martha Wilson
Virginia A Stallings
P2860
P304
P356
10.5414/CP201793
P577
2013-04-01T00:00:00Z